Bringing the fundamentals into focus…
Back to Simulations Plus, Inc.
How Simulations Plus, Inc. stacks up
SLP · against 395 other Healthcare companies of similar size
Valuation
52/ 100
Above the middle of the pack.
Ranked #162 of 396 · scores higher than 58% of peers
Bars: peers in each 10-point band of the valuation score30 peers with a valuation score of 50–59, including SLP · Click a bar to see the companies
Why valuation scores 52?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- EBITDA yield is close to the peer norm. EBITDA yield: 4.6% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 2.2% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 83% of peers. Free cash flow yield: 6.6% vs peer median 0.0%
Metric by metric
Position: dot = SLP, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | SLP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 382 reported | 2.2% | -0.2% | 65% | 30% | |
| EBITDA yieldHigher is better · 399 reported | 4.6% | 2.6% | 58% | 50% | |
| Free cash flow yieldHigher is better · 188 reported | 5.8% | -9.1% | 88% | 20% | |
| Book yieldHigher is better · 391 reported | 37.2% | 50.1% | 38% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around SLPScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score